Zobrazeno 1 - 10
of 22
pro vyhledávání: '"David A, Katzenstein"'
Publikováno v:
International Journal of Infectious Diseases, Vol 109, Iss , Pp 92-98 (2021)
Objectives: The aim of this study was to determine the contributions of intrauterine (IU), intrapartum (IP), and postpartum (PP) transmission to mother-to-child transmission of HIV-1 (MTCT) and infant mortality in the first 6 months of life, in the e
Externí odkaz:
https://doaj.org/article/3f6c4a6a5d3a40cdbb6c7579cee25b2e
Autor:
Seble G. Kassaye, Zehava Grossman, Priyanka Vengurlekar, William Chai, Megan Wallace, Soo-Yon Rhee, William A. Meyer, Harvey W. Kaufman, Amanda Castel, Jeanne Jordan, Keith A. Crandall, Alisa Kang, Princy Kumar, David A. Katzenstein, Robert W. Shafer, Frank Maldarelli
Publikováno v:
Viruses, Vol 15, Iss 1, p 68 (2022)
Background: Molecular epidemiological approaches provide opportunities to characterize HIV transmission dynamics. We analyzed HIV sequences and virus load (VL) results obtained during routine clinical care, and individual’s zip-code location to det
Externí odkaz:
https://doaj.org/article/f8d7ad8359b940c4ad25ebdfe597dd83
Autor:
Megan B. Fitzpatrick, Racheal S. Dube Mandishora, David A. Katzenstein, Kathy McCarty, Jenna Weber, Malaya K. Sahoo, Justen Manasa, Zvavahera Mike Chirenje, Benjamin A. Pinsky
Publikováno v:
International Journal of Infectious Diseases, Vol 82, Iss , Pp 21-29 (2019)
Objectives: High-risk human papilloma viruses (hrHPV) are the causative agents of cervical cancer, the leading cause of cancer deaths among Zimbabwean women. The objective of this study was to describe the hrHPV types found in Zimbabwe for considerat
Externí odkaz:
https://doaj.org/article/2ee5e44c252347f6b33cdedbb7ea7848
Autor:
Lynn Sodai Zijenah, Tsitsi Bandason, Wilbert Bara, Maria Mary Chipiti, David Allan Katzenstein
Publikováno v:
AIDS Patient Care and STDs. 36:145-152
Autor:
Roger Paredes, Philip L Tzou, Gert van Zyl, Geoff Barrow, Ricardo Camacho, Sergio Carmona, Philip M Grant, Ravindra K Gupta, Raph L Hamers, P Richard Harrigan, Michael R Jordan, Rami Kantor, David A Katzenstein, Daniel R Kuritzkes, Frank Maldarelli, Dan Otelea, Carole L Wallis, Jonathan M Schapiro, Robert W Shafer
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181357 (2017)
HIV-1 genotypic resistance test (GRT) interpretation systems (IS) require updates as new studies on HIV-1 drug resistance are published and as treatment guidelines evolve.An expert panel was created to provide recommendations for the update of the St
Externí odkaz:
https://doaj.org/article/1e4b1cc89b67468c95603cd7d02e4c37
Autor:
Barbara A Rath, Kaveh Pouran Yousef, David K Katzenstein, Robert W Shafer, Christof Schütte, Max von Kleist, Thomas C Merigan
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61102 (2013)
Effectiveness of ART regimens strongly depends upon complex interactions between the selective pressure of drugs and the evolution of mutations that allow or restrict drug resistance.Four clinical isolates from NRTI-exposed, NNRTI-naive subjects were
Externí odkaz:
https://doaj.org/article/d9873824528846a0acfdb1f5b3e50b29
Autor:
Rami Kantor, David A Katzenstein, Brad Efron, Ana Patricia Carvalho, Brian Wynhoven, Patricia Cane, John Clarke, Sunee Sirivichayakul, Marcelo A Soares, Joke Snoeck, Candice Pillay, Hagit Rudich, Rosangela Rodrigues, Africa Holguin, Koya Ariyoshi, Maria Belen Bouzas, Pedro Cahn, Wataru Sugiura, Vincent Soriano, Luis F Brigido, Zehava Grossman, Lynn Morris, Anne-Mieke Vandamme, Amilcar Tanuri, Praphan Phanuphak, Jonathan N Weber, Deenan Pillay, P Richard Harrigan, Ricardo Camacho, Jonathan M Schapiro, Robert W Shafer
Publikováno v:
PLoS Medicine, Vol 2, Iss 4, p e112 (2005)
The genetic differences among HIV-1 subtypes may be critical to clinical management and drug resistance surveillance as antiretroviral treatment is expanded to regions of the world where diverse non-subtype-B viruses predominate.To assess the impact
Externí odkaz:
https://doaj.org/article/3c6e1b089cef4377b9ab2b69bc81d481
Publikováno v:
The Journal of Infectious Diseases. 188:537-540
Virologic outcome among 104 lamivudine (3TC)-experienced individuals infected with human immunodeficiency virus type 1 who switched to a didanosine (ddI)-containing triple- or quadruple-drug regimen was compared with those who continued receiving a 3
Autor:
M. Tucker, S. Ryan, A. C. Collier, Michael T. Ryan, K. Kieburtz, S. A. Chafey, B. Smith, R. Mitsuyasu, Richard W. Price, Pieter Gerits, M. Shoemaker, R. Reichman, Giovanni Schifitto, C. Van Der Horst, William G. Powderly, Anthony P. Geraci, J. Maenza, E. Singer, K. Gray, J. R. Berger, Michael Rubin, V. Rexrod, Elizabeth A. Miller, C. Kapoor, C. Hall, Anna-Bettina Haidich, D. Slamowitz, L. Ponticello, J. Phair, John Bartlett, Justin C. McArthur, David A. Katzenstein, D. Cummings, A. Nath, Richard B. Pollard, Bruce A. Cohen, C. Cooper, A. Davidson, R. Greenberg, S. Hillman, B. Navia, C. Rask, D. McGuire, T. Flynn, J. Mendell, Robert R. McKendall, Henry S. Sacks, S. Shriver, W. Robertson, E. Caten, David B. Clifford, R. Becker, A. Khan, E. McCarthy, M. Jacobson, R. McVey, B. Adornato, H. Hollander, M. Freimer, Linda Millar, David M. Simpson, I. Zaprianova, M. Glicksman, Robert L. Murphy, M. Hirsch, Michael M. Lederman, J. Norris, S. Klenner, Constantin T. Yiannoutsos, C. Marra, S. Valle, K. Carter
Publikováno v:
AIDS. 16:407-412
Objective: To determine if there is an association between plasma HIV-1 RNA levels and severity of HIV-associated distal symmetrical polyneuropathy (DSP). Design: Substudy of AIDS Clinical Trials Group Protocol 291, a double-blind, placebo-controlled
Autor:
David A. Katzenstein, Michael Katzman, Patricia Reichelderfer, Susan A. Fiscus, Phalguni Gupta, William A. Meyer, Robert W. Coombs, Victor DeGruttola, Margaret V. Ragni, Marsha L. LoFaro
Publikováno v:
Journal of Infectious Diseases. 171:305-311
A quantitative cell microculture assay (QMC) was used to measure the human immunodeficiency virus type 1 (HIV-1) peripheral blood mononuclear cell (PBMC)-associated titer in 109 subjects rolled in an open-label phase I/II study of didanosine monother